AIM ImmunoTech Long Term Deferred Assets (Quarterly) Insights

AIM ImmunoTech, Inc. (AIM)

1.17 -0.17 (-12.69%) USD | NYAM | Jan 20, 15:15

View Long Term Deferred Assets (Quarterly) for AIM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Halozyme Therapeutics, Inc.	Upgrade
Perspective Therapeutics, Inc.	--
Protalix Biotherapeutics, Inc.	Upgrade
Electromed, Inc.	Upgrade
Armata Pharmaceuticals, Inc.	--